Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Christine Perret
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Physiology
Genes & Molecular Sequences
Anatomy
Concepts & Ideas
Disorders
Sign-in to see full Profile
Network (preview)
19
Colnot, Sabine
16
Romagnolo, Béatrice
15
Kahn, Axel
8
Godard, Cécile
6
Porteu, Arlette
6
Vandewalle, Alain
5
Dupret, Jean-Marie
5
Fabre, Monique
5
Decaens, Thomas
4
Dagher, Georges
4
de La Coste, Alix
4
Benhamouche, Samira
4
Audard, Virginie
4
Bouillier, Hélène
4
Buendia, Marie Annick
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Christine Perret (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Zagani Rachid; Hamzaoui Nadim; Cacheux Wulfran; de Reyniès Aurélien; Terris Benoît; Chaussade Stanislas; Romagnolo Béatrice; Perret Christine; Lamarque Dominique
Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Gastroenterology 2009;137(4):1358-66.e1-3.
-
2009: Chafey Philippe; Finzi Laetitia; Boisgard Raphael; Caüzac Michèle; Clary Guillem; Broussard Cédric; Pégorier Jean-Paul; Guillonneau François; Mayeux Patrick; Camoin Luc; Tavitian Bertrand; Colnot Sabine; Perret Christine
Proteomic analysis of beta-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway.
Proteomics 2009;9(15):3889-900.
-
2009: Cavard Catherine; Audebourg Anne; Letourneur Franck; Audard Virginie; Beuvon Frédéric; Cagnard Nicolas; Radenen Brigitte; Varlet Pascale; Vacher-Lavenu Marie-Cécile; Perret Christine; Terris Benoit
Gene expression profiling provides insights into the pathways involved in solid pseudopapillary neoplasm of the pancreas.
The Journal of pathology 2009;218(2):201-9.
-
2008: Andreu Pauline; Peignon Grégory; Slomianny Christian; Taketo Makoto M; Colnot Sabine; Robine Sylvie; Lamarque Dominique; Laurent-Puig Pierre; Perret Christine; Romagnolo Béatrice
A genetic study of the role of the Wnt/beta-catenin signalling in Paneth cell differentiation.
Developmental biology 2008;324(2):288-96.
-
2008: Cavard Catherine; Colnot Sabine; Audard Virginie; Benhamouche Samira; Finzi Laetitia; Torre Cyril; Grimber Gisèle; Godard Cécile; Terris Benoit; Perret Christine
Wnt/beta-catenin pathway in hepatocellular carcinoma pathogenesis and liver physiology.
Future oncology (London, England) 2008;4(5):647-60.
-
2008: Decaens Thomas; Godard Cécile; de Reyniès Aurélien; Rickman David S; Tronche François; Couty Jean-Pierre; Perret Christine; Colnot Sabine
Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate.
Hepatology (Baltimore, Md.) 2008;47(1):247-58.
-
2007: Audard V; Grimber G; Elie C; Radenen B; Audebourg A; Letourneur F; Soubrane O; Vacher-Lavenu M-C; Perret C; Cavard C; Terris B
Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.
The Journal of pathology 2007;212(3):345-52.
-
2007: Renard Claire-Angélique; Labalette Charlotte; Armengol Carolina; Cougot Delphine; Wei Yu; Cairo Stefano; Pineau Pascal; Neuveut Christine; de Reyniès Aurélien; Dejean Anne; Perret Christine; Buendia Marie-Annick
Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Cancer research 2007;67(3):901-10.
-
2007: Zucman-Rossi J; Benhamouche S; Godard C; Boyault S; Grimber G; Balabaud C; Cunha A S; Bioulac-Sage P; Perret C
Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.
Oncogene 2007;26(5):774-80.
-
2006: Benhamouche Samira; Decaens Thomas; Perret Christine; Colnot Sabine
[Wnt/beta-catenin pathway and liver metabolic zonation: a new player for an old concept]
Médecine sciences : M/S 2006;22(11):904-6.
-
2006: Andreu Pauline; Perret Christine; Romagnolo Béatrice
[Wnt and gastrointestinal stem cells: dangerous connections]
Médecine sciences : M/S 2006;22(8-9):693-5.
-
2006: Benhamouche Samira; Decaens Thomas; Godard Cécile; Chambrey Régine; Rickman David S; Moinard Christophe; Vasseur-Cognet Mireille; Kuo Calvin J; Kahn Axel; Perret Christine; Colnot Sabine
Apc tumor suppressor gene is the "zonation-keeper" of mouse liver.
Developmental cell 2006;10(6):759-70.
-
2006: Andreu Pauline; Colnot Sabine; Godard Cécile; Laurent-Puig Pierre; Lamarque Dominique; Kahn Axel; Perret Christine; Romagnolo Béatrice
Identification of the IFITM family as a new molecular marker in human colorectal tumors.
Cancer research 2006;66(4):1949-55.
-
2006: Cavard C; Terris B; Grimber G; Christa L; Audard V; Radenen-Bussiere B; Simon M-T; Renard C-A; Buendia M-A; Perret C
Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations.
Oncogene 2006;25(4):599-608.
-
2005: Tissier Frédérique; Cavard Catherine; Groussin Lionel; Perlemoine Karine; Fumey Gwladys; Hagneré Anne-Marie; René-Corail Fernande; Jullian Eric; Gicquel Christine; Bertagna Xavier; Vacher-Lavenu Marie-Cécile; Perret Christine; Bertherat Jérôme
Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
Cancer research 2005;65(17):7622-7.
-
2005: Colnot Sabine; Decaens Thomas; Perret Christine
[Activating a beta-catenin signal in the liver is oncogenic]
Médecine sciences : M/S 2005;21(4):355-7.
-
2005: Andreu Pauline; Colnot Sabine; Godard Cécile; Gad Sophie; Chafey Philippe; Niwa-Kawakita Michiko; Laurent-Puig Pierre; Kahn Axel; Robine Sylvie; Perret Christine; Romagnolo Béatrice
Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine.
Development (Cambridge, England) 2005;132(6):1443-51.
-
2004: Colnot S; Decaens T; Niwa-Kawakita M; Godard C; Hamard G; Kahn A; Giovannini M; Perret C
Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(49):17216-21.
-
2004: Colnot Sabine; Niwa-Kawakita Michiko; Hamard Ghislaine; Godard Cécile; Le Plenier Servane; Houbron Christophe; Romagnolo Béatrice; Berrebi Dominique; Giovannini Marco; Perret Christine
Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers.
Laboratory investigation; a journal of technical methods and pathology 2004;84(12):1619-30.
-
2004: Ovejero Christine; Cavard Catherine; Périanin Axel; Hakvoort Theodorus; Vermeulen Jacqueline; Godard Cécile; Fabre Monique; Chafey Philippe; Suzuki Kazuo; Romagnolo Béatrice; Yamagoe Satoshi; Perret Christine
Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver.
Hepatology (Baltimore, Md.) 2004;40(1):167-76.
-
2002: Cadoret Axelle; Ovejero Christine; Terris Benoit; Souil Evelyne; Lévy Laurence; Lamers Wouter H; Kitajewski Jan; Kahn Axel; Perret Christine
New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism.
Oncogene 2002;21(54):8293-301.
-
2001: Saadi-Kheddouci S; Berrebi D; Romagnolo B; Cluzeaud F; Peuchmaur M; Kahn A; Vandewalle A; Perret C
Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene.
Oncogene 2001;20(42):5972-81.
-
2001: Cadoret A; Ovejero C; Saadi-Kheddouci S; Souil E; Fabre M; Romagnolo B; Kahn A; Perret C
Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.
Cancer research 2001;61(8):3245-9.
-
2000: Colnot S; Ovejero C; Romagnolo B; Porteu A; Lacourte P; Thomasset M; Perret C
Transgenic analysis of the response of the rat calbindin-D 9k gene to vitamin D.
Endocrinology 2000;141(7):2301-8.
-
2000: Bouillier H; Samain E; Miserey S; Perret C; Renaud J F; Safar M; Dagher G
Transforming growth factor-beta1 modulates angiotensin II-induced calcium release in vascular smooth muscle cells from spontaneously hypertensive rats.
Journal of hypertension 2000;18(6):733-42.
-
2000: Renard C A; Fourel G; Bralet M P; Degott C; De La Coste A; Perret C; Tiollais P; Buendia M A
Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.
Oncogene 2000;19(22):2678-86.
-
2000: Samain E; Bouillier H; Miserey S; Perret C; Renaud J F; Safar M; Dagher G
Extracellular signal-regulated kinase pathway is involved in basic fibroblast growth factor effect on angiotensin II-induced Ca(2+) transient in vascular smooth muscle cell from Wistar-Kyoto and spontaneously hypertensive rats.
Hypertension 2000;35(1 Pt 1):61-7.
-
1999: de La Coste A; Mignon A; Fabre M; Gilbert E; Porteu A; Van Dyke T; Kahn A; Perret C
Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.
Cancer research 1999;59(19):5017-22.
-
1999: de la Coste A; Fabre M; McDonell N; Porteu A; Gilgenkrantz H; Perret C; Kahn A; Mignon A
Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice.
The American journal of physiology 1999;277(3 Pt 1):G702-8.
-
1999: Romagnolo B; Berrebi D; Saadi-Keddoucci S; Porteu A; Pichard A L; Peuchmaur M; Vandewalle A; Kahn A; Perret C
Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin.
Cancer research 1999;59(16):3875-9.
-
1999: Samain E; Bouillier H; Perret C; Safar M; Dagher G
ANG II-induced Ca(2+) increase in smooth muscle cells from SHR is regulated by actin and microtubule networks.
The American journal of physiology 1999;277(2 Pt 2):H834-41.
-
1999: Samain E; Dagher G; Bouillier H; Perret C; Droy-Lefaix M T; Safar M; Renaud J F
Dual effect of cicletanine on the Na+-H+ exchanger in chick embryonic cardiomyocytes.
Journal of cardiovascular pharmacology 1999;33(1):169-72.
-
1998: Colnot S; Romagnolo B; Lambert M; Cluzeaud F; Porteu A; Vandewalle A; Thomasset M; Kahn A; Perret C
Intestinal expression of the calbindin-D9K gene in transgenic mice. Requirement for a Cdx2-binding site in a distal activator region.
The Journal of biological chemistry 1998;273(48):31939-46.
-
1998: de La Coste A; Romagnolo B; Billuart P; Renard C A; Buendia M A; Soubrane O; Fabre M; Chelly J; Beldjord C; Kahn A; Perret C
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(15):8847-51.
-
1997: Perret C; Colnot S; Romagnolo B; Thomasset M
Control of nuclear transcription of vitamin D-dependent genes by vitamin D.
Current opinion in nephrology and hypertension 1997;6(4):314-20.
-
1996: Romagnolo B; Molina T; Leroy G; Blin C; Porteux A; Thomasset M; Vandewalle A; Kahn A; Perret C
Estradiol-dependent uterine leiomyomas in transgenic mice.
The Journal of clinical investigation 1996;98(3):777-84.
-
1996: Romagnolo B; Cluzeaud F; Lambert M; Colnot S; Porteu A; Molina T; Tomasset M; Vandewalle A; Kahn A; Perret C
Tissue-specific and hormonal regulation of calbindin-D9K fusion genes in transgenic mice.
The Journal of biological chemistry 1996;271(28):16820-6.
-
1996: Blin C; L'Horset F; Romagnolo B; Colnot S; Lambert M; Thomasset M; Kahn A; Vandewalle A; Perret C
Functional and growth properties of a myometrial cell line derived from transgenic mice: effects of estradiol and antiestrogens.
Endocrinology 1996;137(6):2246-53.
-
1996: Lambert M; Colnot S; Suh E; L'Horset F; Blin C; Calliot M E; Raymondjean M; Thomasset M; Traber P G; Perret C
cis-Acting elements and transcription factors involved in the intestinal specific expression of the rat calbindin-D9K gene: binding of the intestine-specific transcription factor Cdx-2 to the TATA box.
European journal of biochemistry / FEBS 1996;236(3):778-88.
-
1995: Blin C; L'Horset F; Leclerc T; Lambert M; Colnot S; Thomasset M; Perret C
Contrasting effects of tamoxifen and ICI 182 780 on estrogen-induced calbindin-D 9k gene expression in the uterus and in primary culture of myometrial cells.
The Journal of steroid biochemistry and molecular biology 1995;55(1):1-7.
-
1995: Colnot S; Lambert M; Blin C; Thomasset M; Perret C
Identification of DNA sequences that bind retinoid X receptor-1,25(OH)2D3-receptor heterodimers with high affinity.
Molecular and cellular endocrinology 1995;113(1):89-98.
-
1994: L'Horset F; Blin C; Colnot S; Lambert M; Thomasset M; Perret C
Calbindin-D9k gene expression in the uterus: study of the two messenger ribonucleic acid species and analysis of an imperfect estrogen-responsive element.
Endocrinology 1994;134(1):11-8.
-
1993: L'Horset F; Blin C; Brehier A; Thomasset M; Perret C
Estrogen-induced calbindin-D 9k gene expression in the rat uterus during the estrous cycle: late antagonistic effect of progesterone.
Endocrinology 1993;132(2):489-95.
-
1992: Dupret J M; L'Horset F; Perret C; Bernaudin J F; Thomasset M
Calbindin-D9K gene expression in the lung of the rat. Absence of regulation by 1,25-dihydroxyvitamin D3 and estrogen.
Endocrinology 1992;131(6):2643-8.
-
1991: Perret C; L'Horset F; Thomasset M
DNase I-hypersensitive sites are associated, in a tissue-specific manner, with expression of the calbindin-D9k-encoding gene.
Gene 1991;108(2):227-35.
-
1990: L'Horset F; Perret C; Brehier A; Thomasset M
17 beta-estradiol stimulates the calbindin-D9k (CaBP9k) gene expression at the transcriptional and posttranscriptional levels in the rat uterus.
Endocrinology 1990;127(6):2891-7.
-
1990: Thomasset M; Dupret J M; Brehier A; Perret C
Calbindin-D9K (CaBP9K) gene: a model for studying the genomic actions of cacitriol and calcium in mammals.
Advances in experimental medicine and biology 1990;269():35-6.
-
1990: Thomasset M; Lomri N; L'horset F; Brehier A; Dupret J M; Perret C
[Structure, expression and control of calbindins-D]
Annales d'endocrinologie 1990;51(3-4):108-11.
-
1989: Lomri N; Perret C; Gouhier N; Thomasset M
Cloning and analysis of calbindin-D28K cDNA and its expression in the central nervous system.
Gene 1989;80(1):87-98.
-
1988: Perret C; Lomri N; Gouhier N; Auffray C; Thomasset M
The rat vitamin-D-dependent calcium-binding protein (9-kDa CaBP) gene. Complete nucleotide sequence and structural organization.
European journal of biochemistry / FEBS 1988;172(1):43-51.
-
1987: Dupret J M; Brun P; Perret C; Lomri N; Thomasset M; Cuisinier-Gleizes P
Transcriptional and post-transcriptional regulation of vitamin D-dependent calcium-binding protein gene expression in the rat duodenum by 1,25-dihydroxycholecalciferol.
The Journal of biological chemistry 1987;262(34):16553-7.
-
1987: Brun P; Dupret J M; Perret C; Thomasset M; Mathieu H
Vitamin D-dependent calcium-binding proteins (CaBPs) in human fetuses: comparative distribution of 9K CaBP mRNA and 28K CaBP during development.
Pediatric research 1987;21(4):362-7.
-
1985: Thomasset M; Perret C; Brehier A; Balmain N; Cuisinier-Gleizes P; Mathieu H
[Molecular approach to the action of vitamin D in man]
Archives françaises de pédiatrie 1985;42(3):231-6.
Sign-in to see more